Table 3.
GLM-MANOVA test of the overall effect of the sociodemographic and clinical variables on the EORTC QLQ-C30 and H&N35 scales
| QLQ-C30 | QLQ-H&N35 | |||||||
|---|---|---|---|---|---|---|---|---|
| One-factor model* | Multifactor model** | One-factor model* | Multifactor model** | |||||
| Variable | Wilk's λ | p | Wilk's λ | p | Wilk's λ | p | Wilk's λ | p |
| Sociodemographic variables | ||||||||
| Age: <40 v 40~60 v ≥ 60 years | 0.922 | 0.016 | 0.942 | NS | 0.926 | 0.013 | 0.939 | NS |
| Gender: female v male | 0.890 | <0.01 | 0.877 | <0.01 | 0.919 | 0.018 | 0.963 | NS |
| Education years: ≤ 6 v 6~12 v >12 | 0.914 | 0.011 | 0.928 | NS | 0.920 | 0.033 | 0.941 | NS |
| Marital status: with v without spouse | 0.958 | 0.042 | 0.951 | NS | 0.975 | NS | 0.968 | NS |
| Annual family income: < 0.6 v 0.6~1.2 v ≥ 1.2 (million NTD) | 0.845 | <0.01 | 0.896 | 0.032 | 0.866 | <0.01 | 0.910 | NS |
| Clinical variables | ||||||||
| CCI score: 0 v ≥ 1 | 0.937 | 0.001 | 0.910 | NS | 0.965 | NS | 0.935 | NS |
| Tumor site: Oral cavity v Oropharynx v Hypopharynx/Larynx v Nasopharynx | 0.805 | <0.01 | 0.828 | <0.01 | 0.618 | <0.01 | 0.824 | <0.01 |
| AJCC stage: stage I-II v III-IV | 0.870 | <0.01 | 0.863 | <0.01 | 0.880 | <0.01 | 0.869 | NS |
| Treatment methods: S + RT v S + RT+ C/T v RT±C/T | 0.865 | <0.01 | 0.845 | <0.01 | 0.832 | <0.01 | 0.906 | NS |
| RT technique: 2DRT v 3DCRT v IMRT | 0.888 | <0.01 | 0.876 | <0.01 | 0.869 | <0.01 | 0.829 | <0.01 |
| Follow-up years: 2~3 v 3~5 v > 5 | 0.937 | NS | 0.928 | NS | 0.933 | NS | 0.938 | NS |
*: The one factor model: only one independent variable was entered into the model. **: The multifactor model: all mentioned variables were entered as independent variables in the model. Abbreviations: GLM-MANOVA: general linear model multivariate of variance; EORTC QLQ-C30: European Organization for Research and Treatment of Cancer Quality of Life Core questionnaire; H&N35: Head and Neck Module; NTD: New Taiwan Dollar (1 USD = 33 NTD); CCI: Charlson comorbidity index; AJCC: American Joint of Cancer Committee published in 2002; S: surgery; RT: radiotherapy; C/T: chemotherapy; 2DRT: two dimensional RT; 3DCRT: three dimensional conformal RT; IMRT: intensity modulated RT; NS: not significant.